Enfamil Neuropro Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Similac is the best-performing enfamil neuropro brand in July 2026, moving 39,000 units across 4 ASINs for 53.4% of Top 10 volume. Enfamil follows with 11,000 units (15.1%), ahead of Bubs on 10,000 units (13.7%).

With 6 brands splitting the Top 10 and 82.2% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $33.29 to $64.67, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, 2 ASINs forced its way in: B0CLXZJK1M booked 4K units at $45.89, with ▲ 0.0% MoM change. On the growth side, B09DTGC3MC leads positive momentum with ▲ 100.0% MoM growth on 20K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.